ArticleInternational journal of surgery (London, England)2026
Comparison Between endoscopic submucosal dissection and laparoscopic endoscopic cooperative surgery for non-ampullary duodenal neuroendocrine tumors: a single-center retrospective cohort study.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeuroendocrine tumors (NETs) are relatively rare in the duodenum. We aimed to compare the clinical outcomes of endoscopic submucosal dissection (ESD) and laparoscopic endoscopic cooperative surgery (LECS) for non-ampullary duodenal NETs. MATERIALS AND
methodsThis single-center retrospective study included patients with non-ampullary duodenal NETs treated with ESD or LECS between 2010 and 2024. Data on patient demographics, surgical outcomes, and short- and long-term prognoses were collected.
resultsWe enrolled a total of 29 patients. No significant differences were observed between the ESD and LECS groups with regard to sex, age, height, weight, or tumor location. The median tumor diameter was significantly larger in the LECS group than in the ESD group (12.00 mm vs. 5.00 mm). The tumors in the LECS group were located deeper (submucosa or muscularis propria) than those in the ESD group. Both groups achieved high rates of en bloc resection (100% for ESD and 100% for LECS) and R0 resection (100% for ESD and 93.3% for LECS). There were no significant differences in postoperative complications, such as bleeding, stenosis, or abdominal infection between groups. The median duration of hospitalization was longer in the LECS group than in the ESD group (11.00 vs. 7.00 days). No recurrence or metastasis was observed in either group during follow-up.
conclusionBoth ESD and LECS demonstrated high en bloc resection rates and R0 resection rates, along with favorable short- and long-term prognoses for non-ampullary duodenal NETs. LECS appears to be a safe and effective treatment option with an efficacy comparable to that of ESD and may be suitable for larger or deeply infiltrating lesions, potentially helping avoid the need for more invasive surgical procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.